Skip to main content

Panel of 48 CSF Proteins Complements Existing Alzheimer Biomarkers

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Sept. 7, 2023 -- A panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of Science Translational Medicine.

Rafi Haque, M.D., Ph.D., from the Emory University School of Medicine in Atlanta, and colleagues developed a reliable and high-throughput mass spectrometry-selected reaction monitoring assay that targets 48 key proteins altered in the CSF, as identified in previous work. The diagnostic utility of the protein panel was examined in CSF collected at baseline visits from 706 participants recruited from the Alzheimer’s Disease Neuroimaging Initiative (ADNI).

The researchers found that at least as good performance was seen for the CSF 48 panel as compared with existing AD CSF biomarkers (amyloid β42, tTau, and pTau181) for predicting clinical diagnosis, fluorodeoxyglucose (FDG), positron emission tomography (PET), hippocampal volume, and measures of cognitive and dementia severity. The CSF 48 panel plus the existing AD CSF biomarkers significantly improved diagnostic performance for each of these outcomes. Compared with either measure alone, the CSF 48 panel plus existing AD CSF biomarkers significantly improved predictions for changes in FDG PET, hippocampal volume, and measures of cognitive decline and dementia severity.

"The CSF 48 panel improves upon existing AT(N) [amyloid plaques, neurofibrillary tangles, and neurodegeneration] biomarkers to predict many pathophysiological mechanisms linked to AD and AD-related dementia brain; distinguish pathophysiological mechanisms based on their proteomic signature; and improve the prediction of disease progression and future changes in cognition, dementia severity, and hippocampal volume," the authors write.

ADNI was partially supported by pharmaceutical companies.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

Self-, Partner-Reported Cognitive Decline Linked to Tau

THURSDAY, May 30, 2024 -- Individuals who self-report and whose partners report cognitive decline have greater tau, which is driven by elevated beta-amyloid (Aβ), according...

Socioeconomic Status Transitions Tied to Dementia Risk

THURSDAY, May 23, 2024 -- Upward and downward socioeconomic status (SES) transitions are associated with the risk for dementia and the length of dementia-free periods during the...

Ultraprocessed Food Consumption Linked to Cognitive Impairment, Stroke

THURSDAY, May 23, 2024 -- The levels of food processing is associated with cognitive impairment and stroke, according to a study published online May 22 in Neurology. Varun M...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.